High cost drugs - Risankizumab
Codelist metadata
-
Coding system
- No coding system
-
Coding system release
- unknown
-
Organisation
- OpenSAFELY
-
Codelist ID
- opensafely/high-cost-drugs-risankizumab
-
Version ID
- 60a81e58
Versions
About
Description
This is a list of all the unique values from the Drug Name variable in the High Cost Drugs Dataset that relate to the prescribing of risankizumab.
Methodology
The values in this variable do not follow a coding system so the selection for this codelist is based on the drug name value, after converting all text to lower case, containing one or more of the following strings (these are the generic medicine name and brand names):
- risankizumab
- skyrizi
All drug name values that contain at least one of the above strings are included in the risankizumab group and assigned the VTM (virtual therapeutic moiety) code 37138511000001104.
References
Signed off by
- Mark Yates, (Feb. 26, 2021)
- Nick Kennedy, (Feb. 26, 2021)
- Anna Rowan, (Feb. 26, 2021)
- Sinéad langan, (Feb. 26, 2021)
- James Galloway, (Feb. 26, 2021)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
olddrugname |
---|
home-risankizumab 75mg/0.83ml solution for inj pfs |
home - risankizumab 75mg-0.83ml solution for inj pfs |
risankizumab |
risankizumab ( (homecare) |
risankizumab (home) 75 mg subcutaneous injection |
risankizumab (skyrizi - homecare) 75 mg in 0.83ml pre-filled syringe |
risankizumab 75mg in 0.83ml (skyrizi) (homecare) 75 mg pre-filled syringe |
risankizumab 75mg/0.83ml solution for injection (2) |
risankizumab pas scheme (skyrizi) 75 mg pre-filled syringe |
risankizumab pas scheme (skyrizi)_(homecare) 75 mg pre-filled syringe |
skyrizi |
skyrizi (risankizumab) |
skyrizi (risankizumab) (homecare) |